Trial Profile
Proof-of-concept trial of pneumococcal vaccine
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 08 Feb 2016
Price :
$35
*
At a glance
- Drugs Pneumococcal vaccine (Primary)
- Indications Streptococcal infections
- Focus Adverse reactions; Proof of concept
- Sponsors Affinivax
- 08 Feb 2016 New trial record
- 05 Feb 2016 According to Affinivax media release, company is planning for an IND submission.